// App-Quantinova.ai

e16038 : Second-line chemotherapy in older patients with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies.

Researchers

Presenter

  • Samer Salah

Principal Investigators

  • Jae-Lyun Lee

  • Antonio Rozzi

  • Jeremy Howard Lewin

  • Hiroshi Kitamura

  • Kazumasa Matsumoto

  • Daniel J Vis

  • Lodewyk F. A. Wessels

  • Sandy Srinivas

  • Rafael Morales

  • Joan Carles

  • Samar Toubasi

  • Soonil Lee

  • Ki Hong Kim

  • Kouji Izumi

Medical Centers

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Clinical Oncology Unit, Istituto Neurotraumatologico Italiano Grottaferrata, Grottaferrata, Italy

  • Sapporo Medical University School of Medicine, Sapporo, Japan

  • Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands

  • Stanford Univeresity Medical Center, Stanford, CA

  • Oncology Department, University Hospital Vall d'Hebron, Barcelona, Spain

  • Vall d Hebron University Hospital (HUVH) and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada

  • Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

Locations

  • Canada

  • Japan

  • Italy

  • Netherlands

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Advanced Urothelial Carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved